Recall of IMMULITE 2500 SYSTEM - SYSTEM REAGENTS

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by SIEMENS HEALTHCARE LIMITED.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    16660
  • Event Risk Class
    II
  • Event Initiated Date
    2010-05-21
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Specific chemiluminescent substrate lots have been shown to introduce a positive and/or negative bias in both controls and potentially patient results with multiple analytes assayed on the immulite 2000 and/or immulite 2500. siemens healthcare diagnostics has confirmed that the substrate lots may have impacted 31 immulite 2000 and immulite 2500 analytes.

Device

  • Model / Serial
    Model Catalog: L2SUBM (Lot serial: 282); Model Catalog: L2SUBM (Lot serial: 283)
  • Product Description
    IMMULITE 2500 SYSTEM - SYSTEM REAGENTS
  • Manufacturer

Manufacturer

  • Manufacturer Address
    OAKVILLE
  • Manufacturer Parent Company (2017)
  • Source
    HC